Early-onset pancreatic cancer patients benefit more from neoadjuvant chemotherapy and surgery Post author:admin Post published:August 7, 2025 Post category:uncategorized The incidence of early-onset pancreatic cancer (EOPC) is rising, yet optimal treatment strategies remain unclear. You Might Also Like Dementia rates decline among newer generations of older adults June 5, 2025 Common painkillers ibuprofen and paracetamol found to fuel antibiotic resistance August 25, 2025 Genetic and behavioral link found between musicality and language skills October 3, 2025